Other Relevant Articles - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart Association
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research
Percutaneous coronary intervention using a combination of robotics and telecommunications by an operator in a separate physical location from the patient: an early exploration into the feasibility of telestenting (the REMOTE-PCI study)
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation The mSToPS Randomized Clinical Trial
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization
Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology
Syncope After Percutaneous Coronary Intervention
Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation Statement
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial

Original Research

July 15, 2021

JOURNAL：PLoS One.

Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry

LB Daniels, JT Ren, K Kumar et al.

4477

Keywords: COVID-19; CVD patients; statin prevention; death

FULL TEXT PDF